ProShare Advisors’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $447K | Sell |
|
|||||
|
2025
Q1 | $473K | Sell |
|
|||||
|
2024
Q4 | $645K | Buy |
|
|||||
|
2024
Q3 | $431K | Sell |
|
|||||
|
2024
Q2 | $593K | Buy |
|
|||||
|
2024
Q1 | $473K | Buy |
|
|||||
|
2023
Q4 | $372K | Buy |
|
|||||
|
2023
Q3 | $308K | Sell |
|
|||||
|
2023
Q2 | $341K | Buy |
|
|||||
|
2023
Q1 | $401K | Sell |
|
|||||
|
2022
Q4 | $443K | Buy |
|
|||||
|
2022
Q3 | $384K | Buy |
|
|||||
|
2022
Q2 | $323K | Sell |
|
|||||
|
2022
Q1 | $536K | Sell |
|
|||||
|
2021
Q4 | $578K | Buy |
|
|||||
|
2021
Q3 | $507K | Sell |
|
|||||
|
2021
Q2 | $730K | Buy |
|
|||||
|
2021
Q1 | $573K | Buy |
|
|||||
|
2020
Q4 | $502K | Buy |
|
|||||
|
2020
Q3 | $321K | Sell |
|
|||||
|
2020
Q2 | $378K | Buy |
|
|||||
|
2020
Q1 | $197K | Sell |
|
|||||
|
2019
Q4 | $462K | Sell |
|
|||||
|
2019
Q3 | $581K | Sell |
|
|||||
|
2019
Q2 | $727K | Sell |
|
|||||
|
2019
Q1 | $861K | Buy |
|
|||||
|
2018
Q4 | $808K | Sell |
|
|||||
|
2018
Q3 | $1.44M | Sell |
|
|||||
|
2018
Q2 | $1.79M | Sell |
|
|||||
|
2018
Q1 | $1.44M | Sell |
|
|||||
|
2017
Q4 | $1.45M | Buy |
|
|||||
|
2017
Q3 | $1.31M | Buy |
|
|||||
|
2017
Q2 | $1.32M | Sell |
|
|||||
|
2017
Q1 | $1.04M | Sell |
|
|||||
|
2016
Q4 | $1.04M | Buy |
|
|||||
|
2016
Q3 | $928K | Sell |
|
|||||
|
2016
Q2 | $882K | Buy |
|
|||||
|
2016
Q1 | $628K | Sell |
|
|||||
|
2015
Q4 | $607K | Buy |
|
|||||
|
2015
Q3 | $573K | Sell |
|
|||||
|
2015
Q2 | $730K | Buy |
|
|||||
|
2015
Q1 | $487K | Buy |
|
|||||
|
2014
Q4 | $288K | Buy |
|
|||||
|
2014
Q3 | $293K | Sell |
|
|||||
|
2014
Q2 | $436K | Sell |
|
|||||
|
2014
Q1 | $379K | Buy |
|
|||||
|
2013
Q4 | $121K | Sell |
|
|||||
|
2013
Q3 | $149K | Buy |
|